Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Pierre-Michel Llorca, MD
JCP
Article
Extrapyramidal Side Effects and Antipsychotics
January 8, 2019
Extrapyramidal side effects have been identified as frequent side effects of antipsychotics in RCTs with highly selected subjects, but how common are they in nonselected samples? This national multicenter...
David Misdrahi
,
Arnaud Tessier
,
Antoine Daubigney
, et al
JCP
Original Research
Metabolic Syndrome Predicts Relapse in Schizophrenia
September 18, 2018
Cardiovascular diseases are the primary cause of mortality in individuals with schizophrenia, yet no study has yet explored the impact of metabolic syndrome on schizophrenia relapse. This study explored...
Ophelia Godin
,
Marion Leboyer
,
Frank Schürhoff
, et al
JCP
Original Research
Treatment of Schizophrenia With Long-Acting Injectable Risperidone: A 12-Month Open-Label Trial of the First Long-Acting Second-Generation Antipsychotic
October 15, 2003
W. Wolfgang Fleischhacker
,
Mariëlle Eerdekens
,
Keith Karcher
, et al
JCP
Original Research
Efficacy and Safety of Hydroxyzine in the Treatment of Generalized Anxiety Disorder: A 3-Month Double-Blind Study
November 1, 2002
Pierre-Michel Llorca
,
Christian Spadone
,
Olivier Sol
, et al
